JOHN ANTHONY DIYA: Open Payments
NPI 1275095663 · HUNTINGTON BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 40 payments from 8 companies in 2025. Trend: 2023 $1,729 · 2024 $1,456 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $159 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $142 |
| Otsuka America Pharmaceutical, Inc. | 5 | $94 |
| Lundbeck LLC | 3 | $53 |
| Alkermes, Inc. | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $41 |
| ABBVIE INC. | 2 | $37 |
Products named: CAPLYTA, REXULTI, TRINTELLIX, ARISTADA, Auvelity, FANAPT, VRAYLAR.
Industry payments across CA — which companies pay providers there.
